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The Vascular Registry Committee of the New England Society for Vascular Surgery (NESVS) has prospectively evaluated prosthetic bypass grafts. A record of these operations and follow-up data were voluntarily submitted by members of the Society during the last 13 years. The 5-year primary patency rate for 103 axillo-femoral procedures was significantly greater for the bifemoral group (55%) than for the unifemoral group (14%). For infrainguinal reconstruction (402 cases), the 5-year primary patency rates were as follows: 57% (fem-pop AK PTFE claudication); 46% (fem-pop AK PTFE rest pain); 32% (fem-pop AK PTFE necrosis); 26% (fem-pop BK PTFE claudication); 17% (fem-pop BK PTFE rest pain); 21% (fem-pop BK PTFE necrosis); 69% (fem-pop AK umbilical vein); and 45% (fem-pop BK umbilical vein). None of the femoral tibial or peroneal prosthetic bypass grafts remained patent for 5 years. Umbilical vein bypasses may have had a higher patency than PTFE bypass; however, they did develop aneurysmal changes.